Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Neoplasms of the CNS

  Free Subscription


1 Am J Clin Oncol
1 Arch Pathol Lab Med
3 BMC Cancer
1 BMC Neurol
1 Br J Cancer
1 Br J Neurosurg
2 Childs Nerv Syst
4 Clin Cancer Res
5 Int J Radiat Oncol Biol Phys
1 J Clin Oncol
4 J Neurooncol
3 J Neurosurg
8 Neuro Oncol
1 Neurology
4 Neuroradiology
5 Neurosurgery
1 Oncogene
2 PLoS One
3 Radiology

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Clin Oncol

  1. DELAYE M, Benderra MA, Deforceville L, Larghero J, et al
    High-dose Chemotherapy in Germ Cell Cancer Patients With Brain Metastases: Experience of an Expert Center.
    Am J Clin Oncol. 2021 Jun 3. pii: 00000421-900000000-98556.
    PubMed         Abstract available

    Arch Pathol Lab Med

  2. MCDONALD WC, McDonald KN, Helmer JA, Ho B, et al
    The Role of T-box Transcription Factor in a Pituitary Adenoma Diagnostic Algorithm.
    Arch Pathol Lab Med. 2021;145:592-598.
    PubMed         Abstract available

    BMC Cancer

  3. ZHU W, Zhao H, Xu F, Huang B, et al
    The lipid-lowering drug fenofibrate combined with si-HOTAIR can effectively inhibit the proliferation of gliomas.
    BMC Cancer. 2021;21:664.
    PubMed         Abstract available

  4. MOON HH, Kim HS, Park JE, Kim YH, et al
    Refinement of response assessment in neuro-oncology (RANO) using non-enhancing lesion type and contrast enhancement evolution pattern in IDH wild-type glioblastomas.
    BMC Cancer. 2021;21:654.
    PubMed         Abstract available

  5. SHAN Q, Shi J, Wang X, Guo J, et al
    A new nomogram and risk classification system for predicting survival in small cell lung cancer patients diagnosed with brain metastasis: a large population-based study.
    BMC Cancer. 2021;21:640.
    PubMed         Abstract available

    BMC Neurol

  6. TOMOTO K, Fujimoto A, Inenaga C, Okanishi T, et al
    Experience using mTOR inhibitors for subependymal giant cell astrocytoma in tuberous sclerosis complex at a single facility.
    BMC Neurol. 2021;21:139.
    PubMed         Abstract available

    Br J Cancer

  7. ROMINIYI O, Vanderlinden A, Clenton SJ, Bridgewater C, et al
    Correction: Tumour treating fields therapy for glioblastoma: current advances and future directions.
    Br J Cancer. 2021 Jun 10. pii: 10.1038/s41416-021-01451.

    Br J Neurosurg

  8. SCHURING-PEREIRA M, Hagenbeek R, Mast M, Nandoe Tewarie R, et al
    Atypical meningioma: patterns of postradiotherapy recurrences.
    Br J Neurosurg. 2021 Jun 1:1-6. doi: 10.1080/02688697.2021.1922606.
    PubMed         Abstract available

    Childs Nerv Syst

  9. LUNDAR T, Due-Tonnessen BJ
    Outcomes in adulthood after neurosurgical treatment of brain tumors in the first 3 years of life: long-term follow-up of a single consecutive institutional series of 97 patients.
    Childs Nerv Syst. 2021 Jun 11. pii: 10.1007/s00381-021-05130.

  10. ALPHONES S, Chatterjee U, Singh A, Das A, et al
    Immunohistochemical screening for mismatch repair protein deficiency in paediatric high-grade gliomas - institutional experience and review of literature.
    Childs Nerv Syst. 2021 Jun 7. pii: 10.1007/s00381-021-05229.
    PubMed         Abstract available

    Clin Cancer Res

  11. MELLINGHOFF IK, Penas-Prado M, Peters KB, Burris HA, et al
    Vorasidenib, a dual inhibitor of mutant IDH1/2, in recurrent or progressive glioma; Results of a first-in-human Phase I trial.
    Clin Cancer Res. 2021 Jun 2. pii: 1078-0432.CCR-21-0611.
    PubMed         Abstract available

  12. ANWAR M, Chen Q, Ouyang D, Wang S, et al
    Pyrotinib treatment in patients with HER2-positive metastatic breast cancer and brain metastasis: exploratory final analysis of real-world, multicenter data.
    Clin Cancer Res. 2021 Jun 10. pii: 1078-0432.CCR-21-0474.
    PubMed         Abstract available

  13. DI GIACOMO AM, Chiarion-Sileni V, Del Vecchio M, Ferrucci PF, et al
    Primary analysis and four-year follow-up of the phase III NIBIT-M2 trial in melanoma patients with brain metastases.
    Clin Cancer Res. 2021 Jun 10. pii: 1078-0432.CCR-21-1046.
    PubMed         Abstract available

  14. WU AML, Gossa S, Samala R, Chung MA, et al
    Aging and CNS myeloid cell depletion attenuate breast cancer brain metastasis.
    Clin Cancer Res. 2021 Jun 3. pii: 1078-0432.CCR-21-1549.
    PubMed         Abstract available

    Int J Radiat Oncol Biol Phys

  15. PRABHU RS, Dhakal R, Vaslow ZK, Dan T, et al
    Preoperative radiosurgery for resected brain metastases: the PROPS-BM multicenter cohort study.
    Int J Radiat Oncol Biol Phys. 2021 May 28. pii: S0360-3016(21)00666.
    PubMed         Abstract available

  16. YU F, Ni J, Zeng W, Zhou Y, et al
    Clinical value of upfront cranial radiotherapy in osimertinib-treated EGFR-mutant non-small-cell lung cancer with brain metastases.
    Int J Radiat Oncol Biol Phys. 2021 May 28. pii: S0360-3016(21)00667.
    PubMed         Abstract available

  17. BENNAN ABA, Unkelbach J, Wahl N, Salome P, et al
    Joint optimization of photon - carbon ion treatments for Glioblastoma.
    Int J Radiat Oncol Biol Phys. 2021 May 28. pii: S0360-3016(21)00668.
    PubMed         Abstract available

  18. SALANS M, Tibbs MD, Huynh-Le MP, Yip A, et al
    Quality of life is independently associated with neurocognitive function in brain tumor patients: analysis of a prospective clinical trial.
    Int J Radiat Oncol Biol Phys. 2021 Jun 5. pii: S0360-3016(21)00678.
    PubMed         Abstract available

  19. YU X, Christ SM, Liu R, Wang Y, et al
    Evaluation of Long-term Outcomes and Toxicity after Stereotactic Phosphorus-32 Based Intracavitary Brachytherapy in Patients with Cystic Craniopharyngioma.
    Int J Radiat Oncol Biol Phys. 2021 May 28. pii: S0360-3016(21)00665.
    PubMed         Abstract available

    J Clin Oncol

  20. MICHALSKI JM, Janss AJ, Vezina LG, Smith KS, et al
    Children's Oncology Group Phase III Trial of Reduced-Dose and Reduced-Volume Radiotherapy With Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma.
    J Clin Oncol. 2021 Jun 10:JCO2002730. doi: 10.1200/JCO.20.02730.
    PubMed         Abstract available

    J Neurooncol

  21. ADELON J, Dufour C, Foulon S, Masliah Planchon J, et al
    What does a non-response to induction chemotherapy imply in high-risk medulloblastomas?
    J Neurooncol. 2021 Jun 2. pii: 10.1007/s11060-021-03777.
    PubMed         Abstract available

  22. LIU IH, Holtzman AL, Rotondo RL, Indelicato DJ, et al
    Proton therapy for adult medulloblastoma: Acute toxicity and disease control outcomes.
    J Neurooncol. 2021 Jun 8. pii: 10.1007/s11060-021-03783.
    PubMed         Abstract available

  23. CASTRO M, Pampana A, Alam A, Parashar R, et al
    Combination chemotherapy versus temozolomide for patients with methylated MGMT (m-MGMT) glioblastoma: results of computational biological modeling to predict the magnitude of treatment benefit.
    J Neurooncol. 2021 Jun 8. pii: 10.1007/s11060-021-03780.
    PubMed         Abstract available

  24. CHEN YL, Huang AP, Wang CC, Chen HY, et al
    Peri-radiosurgical administration of bevacizumab improves radiographic response to single and fractionated stereotactic radiosurgery for large brain metastasis.
    J Neurooncol. 2021 Jun 7. pii: 10.1007/s11060-021-03782.
    PubMed         Abstract available

    J Neurosurg

  25. SHAH PP, Franke JL, Medikonda R, Jackson CM, et al
    Mutation status and postresection survival of patients with non-small cell lung cancer brain metastasis: implications of biomarker-driven therapy.
    J Neurosurg. 2021 Jun 4:1-11. doi: 10.3171/2020.10.JNS201787.
    PubMed         Abstract available

  26. VIVAS-BUITRAGO T, Domingo RA, Tripathi S, De Biase G, et al
    Influence of supramarginal resection on survival outcomes after gross-total resection of IDH-wild-type glioblastoma.
    J Neurosurg. 2021 Jun 4:1-8. doi: 10.3171/2020.10.JNS203366.
    PubMed         Abstract available

  27. DELLA PEPA GM, D'Alessandris QG, Burattini B, Quaranta D, et al
    Letter to the Editor. Exploring cognitive functions in low-grade glioma surgery.
    J Neurosurg. 2021 Jun 4:1-2. doi: 10.3171/2021.2.JNS21186.

    Neuro Oncol

  28. MARIN BM, Porath KA, Jain S, Kim M, et al
    Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastoma.
    Neuro Oncol. 2021 May 29. pii: 6288409. doi: 10.1093.
    PubMed         Abstract available

  29. PHILLIPS LM, Li S, Gumin J, Daou M, et al
    An immune-competent, replication-permissive Syrian Hamster glioma model for evaluating Delta-24-RGD oncolytic adenovirus.
    Neuro Oncol. 2021 May 31. pii: 6290257. doi: 10.1093.
    PubMed         Abstract available

  30. SCOCCIANTI S, Olmetto E, Pinzi V, Osti MF, et al
    Immunotherapy in association with stereotactic radiotherapy for Non-Small Cell Lung Cancer brain metastases: results from a multicentric retrospective study on behalf of AIRO.
    Neuro Oncol. 2021 May 29. pii: 6288399. doi: 10.1093.
    PubMed         Abstract available

  31. KOTECHA R, Aboian M, Nabavizadeh SA, Parent EE, et al
    Letter regarding "Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients-a report of the PET/RANO group": 18F-fluciclovine and target volume delineation.
    Neuro Oncol. 2021 Jun 3. pii: 6291736. doi: 10.1093.

  32. SHEEHAN J, Pikis S, Islim A, Chen CJ, et al
    An International Multicenter Matched Cohort Analysis of Incidental Meningioma Progression During Active Surveillance or After Stereotactic Radiosurgery: The IMPASSE Study.
    Neuro Oncol. 2021 Jun 9. pii: 6295369. doi: 10.1093.
    PubMed         Abstract available

  33. ERKER C, Lane A, Chaney B, Leary S, et al
    Characteristics of Patients >/= 10 Years of Age with Diffuse Intrinsic Pontine Glioma: A Report from the International DIPG Registry.
    Neuro Oncol. 2021 Jun 11. pii: 6296498. doi: 10.1093.
    PubMed         Abstract available

  34. RIEMONDY KA, Venkataraman S, Willard N, Nellan A, et al
    Neoplastic and immune single cell transcriptomics define subgroup-specific intra-tumoral heterogeneity of childhood medulloblastoma.
    Neuro Oncol. 2021 Jun 2. pii: 6291352. doi: 10.1093.
    PubMed         Abstract available

  35. GALLDIKS N, Niyazi M, Tonn JC, Langen KJ, et al
    Reply to the letter regarding "Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients-a report of the PET/RANO group": 18F-fluciclovine and target volume delineation.
    Neuro Oncol. 2021 Jun 3. pii: 6291737. doi: 10.1093.


  36. GRASSMEYER JJ, Fernandes JA, Helvey JT, Kedar S, et al
    Radiation-Induced Bilateral Oculomotor Nerve Palsy 20 Years After Radiation Treatment.
    Neurology. 2021;96:955-957.


  37. STADLBAUER A, Heinz G, Oberndorfer S, Zimmermann M, et al
    Physiological MRI of microvascular architecture, neovascularization activity, and oxygen metabolism facilitate early recurrence detection in patients with IDH-mutant WHO grade 3 glioma.
    Neuroradiology. 2021 Jun 11. pii: 10.1007/s00234-021-02740.
    PubMed         Abstract available

  38. FLIES CM, Snijders TJ, Van Seeters T, Smits M, et al
    Perfusion imaging with arterial spin labeling (ASL)-MRI predicts malignant progression in lowgrade (WHO grade II) gliomas.
    Neuroradiology. 2021 Jun 11. pii: 10.1007/s00234-021-02737.
    PubMed         Abstract available

  39. VAN DIJKEN BRJ, Schuuring B, Jeltema HR, van Laar PJ, et al
    Ventricle contact may be associated with higher 11C methionine PET uptake in glioblastoma.
    Neuroradiology. 2021 Jun 10. pii: 10.1007/s00234-021-02742.
    PubMed         Abstract available

  40. KATO S, Amemiya S, Takao H, Yamashita H, et al
    Automated detection of brain metastases on non-enhanced CT using single-shot detectors.
    Neuroradiology. 2021 Jun 10. pii: 10.1007/s00234-021-02743.
    PubMed         Abstract available


    In Reply: Commentary: Adjuvant Radiotherapy Versus Watchful Waiting for World Health Organization Grade II Atypical Meningioma: A Single-Institution Experience.
    Neurosurgery. 2021 Jun 7. pii: 6294732. doi: 10.1093.

  42. BRAY DP, Quillin JW, Press RH, Yang Y, et al
    Letter: Commentary: Adjuvant Radiotherapy Versus Watchful Waiting for World Health Organization Grade II Atypical Meningioma: A Single-Institution Experience.
    Neurosurgery. 2021 Jun 5. pii: 6293874. doi: 10.1093.

  43. Erratum to: "Functional Outcomes and Health-Related Quality of Life Following Glioma Surgery" by Philip C De Witt Hamer, MD, PhD, Martin Klein, PhD, Shawn L Hervey-Jumper, MD, Jeffrey S Wefel, PhD, Mitchel S Berger, MD. Neurosurgery, Volume 88, Issue
    Neurosurgery. 2021 Jun 3. pii: 6291730. doi: 10.1093.

  44. GOKDEN M
    Commentary: Neuropathology of Pituitary Adenomas and Sellar Lesions.
    Neurosurgery. 2021 Jan 20. pii: 6105298. doi: 10.1093.

  45. COLE BL
    Neuropathology of Pediatric Brain Tumors: A Concise Review.
    Neurosurgery. 2021 Jun 10. pii: 6296087. doi: 10.1093.
    PubMed         Abstract available


  46. XI S, Cai H, Lu J, Zhang Y, et al
    The pseudogene PRELID1P6 promotes glioma progression via the hnHNPH1-Akt/mTOR axis.
    Oncogene. 2021 Jun 9. pii: 10.1038/s41388-021-01854.
    PubMed         Abstract available

    PLoS One

  47. SHIN C, Kim JM, Cheong JH, Ryu JI, et al
    Association between tumor size and peritumoral brain edema in patients with convexity and parasagittal meningiomas.
    PLoS One. 2021;16:e0252945.
    PubMed         Abstract available

  48. DORRELL MI, Kast-Woelbern HR, Botts RT, Bravo SA, et al
    A novel method of screening combinations of angiostatics identifies bevacizumab and temsirolimus as synergistic inhibitors of glioma-induced angiogenesis.
    PLoS One. 2021;16:e0252233.
    PubMed         Abstract available


  49. LUNA LP, Sherbaf FG, Sair HI, Mukherjee D, et al
    Can Preoperative Mapping with Functional MRI Reduce Morbidity in Brain Tumor Resection? A Systematic Review and Meta-Analysis of 68 Observational Studies.
    Radiology. 2021 Jun 1:204723. doi: 10.1148/radiol.2021204723.
    PubMed         Abstract available

  50. BLIESENER Y, Lebel RM, Acharya J, Frayne R, et al
    Pseudo Test-Retest Evaluation of Millimeter-Resolution Whole-Brain Dynamic Contrast-enhanced MRI in Patients with High-Grade Glioma.
    Radiology. 2021 Jun 8:203628. doi: 10.1148/radiol.2021203628.
    PubMed         Abstract available

    Spatial Resolution versus Reproducibility for Dynamic MRI of High-Grade Gliomas.
    Radiology. 2021 Jun 8:210445. doi: 10.1148/radiol.2021210445.

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.